HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hepatic proteome network data in zebrafish (Danio rerio) liver following dieldrin exposure.

Abstract
Dieldrin is an environmental contaminant that adversely affects aquatic organisms. The data presented in this study are proteomic data collected in liver of zebrafish that were exposed to the pesticide in a dietary exposure. For label free proteomics, data were collected with a quadrupole Time-of-Flight mass spectrometer and for iTRAQ proteomics, data were acquired using a hybrid quadrupole Orbitrap (Q Exactive) MS system. Using formic acid digestion and label free proteomics, 2,061 proteins were identified, and among those, 103 were differentially abundant (p < 0.05 in at least one dose). In addition, iTRAQ proteomics identified 722 proteins in the liver of zebrafish following dieldrin treatment. The label-free approach identified 21 proteins that followed a dose dependent response. Of the differentially abundant proteins identified by iTRAQ, there were 26 unique expression patterns for proteins based on the three doses of dieldrin. Proteins were queried for disease networks to learn more about adverse effects in the liver following dieldrin exposure. Differentially abundant proteins were related to metabolic disease, steatohepatitis and lipid metabolism disorders, drug-induced liver injury, neoplasms, tissue degeneration and liver metastasis. The proteomics data described here is associated with a research article, "Label-free and iTRAQ proteomics analysis in the liver of zebrafish (Danio rerio) following a dietary exposure to the organochlorine pesticide dieldrin" (Simmons et al. 2019). This investigation reveals new biomarkers of toxicity and will be of interest to those studying aquatic toxicology and pesticides.
AuthorsDenina B D Simmons, Andrew M Cowie, Jin Koh, James P Sherry, Christopher J Martyniuk
JournalData in brief (Data Brief) Vol. 25 Pg. 104351 (Aug 2019) ISSN: 2352-3409 [Electronic] Netherlands
PMID31453304 (Publication Type: Journal Article)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: